Cholesteryl ester transfer protein gene ploymorphisms increase the risk of fatty liver in females independent of adisposity
MetadataShow full item record
Background and Aim: Environmental factors including excessive caloric intake lead to disordered lipid metabolism and fatty liver disease (FLD). However, FLD demonstrates heritability suggesting genetic factors are also important. We aimed to use a candidate gene approach to examine the association between FLD and single nucleotide polymorphisms (SNPs) in lipid metabolism genes in the adolescent population-based Western Australian Pregnancy (Raine) Cohort. Methods: A total 951 seventeen year-olds underwent hepatic ultrasound, anthropometric and biochemical characterization, DNA extraction and genotyping for 57 SNPs in seven lipid metabolism genes (ApoB100, ATGL, ABHD5, MTTP, CETP, SREBP-1c, PPARα). Associations were adjusted for metabolic factors and Bonferroni corrected. Results: The prevalence of FLD was 16.2% (11.4% male vs 21.2% female, P = 0.001). Multivariate analysis of metabolic factors found suprailiac skinfold thickness (SST) to be the major predictor of FLD in females and males (odds ratio [OR] 1.11, 95% confidence interval [CI] 1.08-1.15, P = 1.7 × 10−10 and OR 1.17, 95%CI 1.13–1.22, P = 2.4 × 10−11, respectively). In females, two SNPs in linkage disequilibrium from the CETP gene were associated with FLD: rs12447924 (OR 2.16, 95%CI 1.42–3.32, P = 0.0003) and rs12597002 (OR = 2.22, 95%CI 1.46–3.41 P = 0.0002). In lean homozygotes, the probability of FLD was over 30%, compared with 10–15% in lean heterozygotes and 3–5% in lean wild-types. However, these associations were modified by SST, such that for obese individuals, the probability of FLD was over 30% in all genotype groups. Conclusions: Cholesteryl ester transfer protein gene polymorphisms are associated with an increased risk of FLD in adolescent females. The effect is independent of adiposity in homozygotes, thereby placing lean individuals at a significant risk of FLD.
Showing items related by title, author, creator and subject.
Bozaoglu, K.; Curran, J.; Stocker, C.; Zaibi, M.; Segal, D.; Konstantopoulos, N.; Morrison, S.; Carless, M.; Dyer, T.; Cole, S.; Goring, H.; Moses, Eric; Walder, K.; Cawthorne, M.; Blangero, J.; Jowett, J. (2010)Context: Chemerin is a new adipokine associated with obesity and the metabolic syndrome. Gene expression levels of chemerin were elevated in the adipose depots of obese compared with lean animals and was markedly elevated ...
Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthoodLillycrop, K.; Garratt, E.; Titcombe, P.; Melton, Phillip; Murray, R.; Barton, S.; Clarke-Harris, R.; Costello, P.; Holbrook, J.; Hopkins, J.; Childs, C.; Paras-Chavez, C.; Calder, P.; Mori, T.; Beilin, L.; Burdge, G.; Gluckman, P.; Inskip, H.; Harvey, N.; Hanson, M.; Huang, R.; Cooper, C.; Godfrey, K. (2019)Background: The early life environment may influence susceptibility to obesity and metabolic disease in later life through epigenetic processes. SLC6A4 is an important mediator of serotonin bioavailability, and has a key ...
Goh, V.; Hart, William (2015)Objective: This study made use of the percent abdominal fat to define abdominal obesity (AbO) and examined the differential associations of general obesity (GOb) and AbO with age, metabolic and endocrine factors. Methods: ...